Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells

This publication has 24 references indexed in Scilit:

• In vivo and in vitro Modulation of Immune Stimulatory Capacity of Primary Dendritic Cells by Adenovirus-Mediated Gene Transduction
  Experimental and Clinical Immunogenetics, 1998
• Induction of Protective Anti-Tumor Immunity by Gene-Modified Dendritic Cells
  Journal of Immunotherapy, 1998
• Dendritic Cells Infected with PoxvIn Vitro iruses Encoding MART-1/ Melan A Sensitize T Lymphocytes In Vitro
  Journal of Immunotherapy, 1997
• Generation of tumor-specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type 16 E7 epitope
  American Journal of Obstetrics and Gynecology, 1996
• Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
  The Journal of Experimental Medicine, 1996
• Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity.
  The Journal of Experimental Medicine, 1996
• Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.
  The Journal of Experimental Medicine, 1996
• Proliferating dendritic cell progenitors in human blood.
  The Journal of Experimental Medicine, 1994
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
  The Journal of Experimental Medicine, 1994
• The Dendritic Cell System and its Role in Immunogenicity
  Annual Review of Immunology, 1991